These may include MGMT promoter methylation, isocitrate dehydrogenase (IDH) mutations, telomerase reverse transcriptase (TERT) mutations, 1p/19q co-deletion and alpha-thalassemia mental retardation syndrome (ATRX) mutations [25]. This evidence concerns the gene MGMT and alpha thalassemia-intellectual disability syndrome type 1.